Showing results (1-10 of 202) with videos related to
Sort By:
Pageof 21
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2012
Neoadjuvant therapy for ER-positive breast cancersM Colleoni, E MontagnaESMO Open|December 5, 2021
Systematic review and meta-analysis of post-progression outcomes in ER+/HER2- metastatic breast cancer after CDK4/6 inhibitors within randomized clinical trialsE Munzone, E Pagan, V Bagnardi, et al.Zhongguo Yao Li Xue Bao = Acta Pharmacologica Sinica|February 24, 2001
SR141716A induces in rats a behavioral pattern opposite to that of CB1 receptor agonistsB Costa, M ColleoniEuropean Journal of Pharmacology|April 27, 2000
Changes in rat brain energetic metabolism after exposure to anandamide or Delta(9)-tetrahydrocannabinolB Costa, M ColleoniAnnals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2010
Benefits and adverse effects of endocrine therapyM Colleoni, A Giobbie-HurderAnnals of Oncology : Official Journal of the European Society for Medical Oncology|February 17, 2009
A risk score to predict disease-free survival in patients not achieving a pathological complete remission after preoperative chemotherapy for breast cancerM Colleoni, V Bagnardi, N Rotmensz, et al.British Journal of Cancer|May 29, 2008
Factors that predict early treatment failure for patients with locally advanced (T4) breast cancerE Montagna, V Bagnardi, N Rotmensz, et al.European Journal of Pharmacology|October 10, 1996
Chronic cannabinoid, CP-55,940, administration alters biotransformation in the ratB Costa, D Parolaro, M ColleoniTumori|September 1, 1995
Clinical development of new fluoropyrimidines: a major improvement in colorectal cancer treatment?M Colleoni, P Nelli, P ManenteAnnals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2006
Primary systemic therapy on local advance breast cancer, where are we going?S Cinieri, L Orlando, M ColleoniPageof 21